stars 1 stars 2 stars 3

The discovery of new therapeutic uses for drugs that have been developed for other indications is known as drug repurposing. The considerable risks inherent in development are greatly reduced because the repurposed drug has been used in a large number of patients often for many years. This means that it has a well-known safety and pharmacokinetic profile. Moreover, the pharmacology, toxicology, formulation and early clinical trials have been completed greatly reducing costs and shortening the pathway to market. It is now accepted that repurposing offers a much better risk-return trade-off compared with other drug development strategies.

View Top Employees from Xenexus Pharmaceuticals Pty Ltd

Xenexus Pharmaceuticals Pty Ltd Questions

The Xenexus Pharmaceuticals Pty Ltd annual revenue was $5 million in 2023.

Xenexus Pharmaceuticals Pty Ltd is based in North Sydney, New South Wales.

The NAICS codes for Xenexus Pharmaceuticals Pty Ltd are [32541, 3254, 325, 32].

The SIC codes for Xenexus Pharmaceuticals Pty Ltd are [283, 28].

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users